MedTrace Logo

Follow-up Study of COVID-19 Patients in the District Konstanz

NCT04724434 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 526

Last updated 2025-03-12

No results posted yet for this study

Summary

This is a prospective single-center study for the follow-up of SARS-CoV-2 positive patients in the district of Konstanz (LKN). As part of the coronavirus pandemic, patients with SARS-CoV-2 infection are currently being treated in the clinics of the LKN's health network at the Singen (Hegau-Bodensee Clinic) and Konstanz (Konstanz Clinic) locations. So far, there is little data on the long-term effects of SARS-CoV-2 infection. As part of this study, the disease progression of these patients will be monitored. Study objective: Prospective, controlled follow-up observation of SARS-CoV-2 positive patients regarding their secondary diseases and quality of life.

Conditions

  • SARS-CoV-2 Positive Patients

Sponsors & Collaborators

Principal Investigators

  • Marc Kollum, PD Dr. med. · Hegau-Bodensee-Klinikum Singen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-04
Primary Completion
2021-07-17
Completion
2024-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04724434 on ClinicalTrials.gov